Observational studyCancer immunology, immunotherapy : CII2024

Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.

Chao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.